GNH USA

Europe — EMA

Molsidomin Retard Heumann (Molsidomine)

GNH USA supplies Molsidomin Retard Heumann (Molsidomine), a nitric oxide donor for chronic stable angina. Request a quote for global supply worldwide.

Molsidomine

Request sourcing

1
Pack/s

What is Molsidomine?

Molsidomine, the active ingredient in Molsidomin Retard Heumann, is a nitric oxide donor presented as a strength/form for oral use. It treats chronic stable angina in adults.

GNH USA supplies Molsidomin Retard Heumann as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Molsidomine used for?

Molsidomine is used in the management of angina and related cardiovascular conditions.

Chronic stable angina: reduces the frequency of angina attacks and improves exercise tolerance. Ischemic heart disease: provides symptomatic relief of chest pain caused by myocardial ischemia. Coronary artery disease: helps alleviate discomfort during exertion.

What are the side effects of Molsidomine?

Molsidomine may cause several adverse reactions, ranging from mild to serious.

Common Side Effects: - Headache - Dizziness - Flushing - Nausea - Mild hypotension - Tachycardia

Serious or Rare Side Effects: - Severe hypotension - Syncope - Allergic reactions (rash, urticaria) - Angioedema - Rare myocardial infarction - Elevated liver enzymes

What precautions apply to Molsidomine?

When prescribing Molsidomine, consider the following safety measures.

Cardiovascular status: monitor blood pressure and heart rate regularly. Concomitant nitrates: avoid additive hypotensive effects. Renal impairment: use with caution and adjust if necessary. Hepatic impairment: monitor liver function tests. Pregnancy and lactation: safety not established; avoid unless clearly needed. Store at room temperature: keep in the original pack, protect from moisture and light.

What does Molsidomine interact with?

Molsidomine can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Other nitric oxide donors (e.g., nitroglycerin): risk of severe hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): additive vasodilatory effect. - Antihypertensives (e.g., ACE inhibitors): may cause excessive blood pressure drop.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia. - Diuretics: enhance hypotensive effect. - Alcohol: may increase dizziness and hypotension.

Frequently asked questions

What is Molsidomin Retard Heumann used for?+
Molsidomin Retard Heumann contains molsidomine, which is prescribed to relieve symptoms of chronic stable angina by improving blood flow to the heart muscle.
How does molsidomine work in the body?+
Molsidomine is a prodrug that releases nitric oxide after metabolism. The nitric oxide relaxes vascular smooth muscle through the cyclic GMP pathway, causing coronary vasodilation and reducing myocardial oxygen demand.
What is the usual dose of molsidomine?+
The appropriate dose of molsidomine is determined by the prescribing physician based on the patient’s clinical condition, response, and any co‑existing medical issues.
Is molsidomine safe during pregnancy or breastfeeding?+
Safety data for molsidomine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and under medical supervision.
How do I order Molsidomin Retard Heumann from GNH USA?+
Submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does molsidomine compare with other anti‑anginal drugs?+
Molsidomine belongs to the nitric oxide donor class, offering vasodilation without the rapid tolerance seen with nitrates. Compared with beta‑blockers or calcium‑channel blockers, it primarily improves coronary blood flow rather than reducing heart rate or contractility.
What are the storage and handling requirements for Molsidomin Retard Heumann?+
Store the product at room temperature, below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and excessive heat to maintain stability.
How is Molsidomin Retard Heumann administered?+
The medication is taken orally, usually with or without food, as directed by the prescribing clinician. Swallow the tablet whole with a glass of water.
What are the most serious risks associated with molsidomine?+
Serious risks include severe hypotension, syncope, allergic reactions such as angioedema, and rare cases of myocardial infarction. Patients should seek immediate medical attention if they experience sudden dizziness, fainting, or signs of an allergic reaction.
Who should not use molsidomine?+
Molsidomine should be avoided in patients with known hypersensitivity to the drug, those taking other nitric oxide donors, and individuals with severe hypotension or uncontrolled heart failure unless specifically advised by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Molsidomine
Route
Oral Use
Manufacturer
Heumann Pharma Gmbh & Co. Generica Kg
Origin
EU

Related products

Coruno

Coruno

Molsidomine

Therabel Pharma S.A.
EU
Coruno

Coruno

Molsidomine

Therabel Pharma S.A.
EU
Corvasal

Corvasal

Molsidomine

Cheplapharm Arzneimittel Gmbh
EU
Corvaton

Corvaton

Molsidomine

Therabel Pharma S.A.
EU